cotrimoxazole prophylaxis

DRUG2 trials

Sponsors

Institute of Tropical Medicine, Belgium, Harvard School of Public Health (HSPH)

Conditions

AnemiaHIV InfectionsMalaria in PregnancyNeutropenia

Phase 2

Study to Improve Survival Among HIV-Exposed Infants in Botswana

CompletedNCT01229761

Harvard School of Public Health (HSPH)Anemia, HIV Infections, Neutropenia

Start: 2011-05-31End: 2018-10-31Target: 3724Updated: 2019-09-09

Phase 3

Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy

CompletedNCT01053325

Institute of Tropical Medicine, BelgiumHIV Infections, Malaria in Pregnancy

Start: 2010-09-30End: 2013-02-28Updated: 2013-10-24

Related Papers

Are morbidity and mortality estimates from randomized controlled trials externally valid? A comparison of outcomes among infants enrolled into an RCT or a cohort study in Botswana.

2021-10-171 citations

Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.

2017-05-0137 citations

Detecting congenital malformations - Lessons learned from the Mpepu study, Botswana

PLoS ONE2017-03-248 citations

Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting.

2016-10-182 citations